
Yahoo · 14 de sept de 2026
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient sp…
Cardinal Health Inc
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Últimos 203 días · 12/11/25 — 14/09/26
+24.78%
Precio
$ 123.225
Var. %
-1,53%
Volumen operado
40
Precio CAH
US$ 231,86
Teórico (precio / ratio)
CAH ÷ 3
US$ 77,29
Sí, existe el CEDEAR de CAH (Cardinal Health Inc) en la Bolsa de Comercio de Buenos Aires (BYMA). Su ticker local es CAH.
El ticker del CEDEAR de Cardinal Health Inc en Argentina es CAH. La acción subyacente cotiza en NYSE con el símbolo CAH.
El CEDEAR CAH tiene un ratio de 3:1. Eso significa que 3 CEDEARs equivalen a 1 acción de CAH.
El CEDEAR CAH cotiza hoy a $ 123.225 en pesos argentinos, con una variación diaria de -1,53%.
La acción subyacente CAH (Cardinal Health Inc) cotiza a US$ 231,86 en su mercado de origen (NYSE).

Yahoo · 14 de sept de 2026
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient sp…

Yahoo · 14 de sept de 2026
AbbVie is profitable, growing, and paying a rising dividend. CRISPR is burning cash in pursuit of a gene-editing breakthrough that could reshape medicine.

Yahoo · 14 de sept de 2026
McKesson (NYSE:MCK) executives said the company’s first-quarter performance supported a higher full-year earnings outlook, citing broad-based growth across its…
Precio de cierre en pesos argentinos. Fuente: data912.
Cotización
US$ 80,30
vs teórico
+3,9%
Cotización MEP implícita
$ 1.534,56
Cotización
—
vs teórico
—
Cotización Cable implícita
—
El precio teórico del CEDEAR CAH se calcula dividiendo el precio de CAH por el ratio (3). Hoy resulta en US$ 77,29.
En BYMA podés operar CAH en pesos, CAHD en dólar MEP y CAHC en dólar cable. Cada modalidad refleja un tipo de cambio distinto.
En esta página encontrás un gráfico con el precio histórico del CEDEAR CAH en pesos argentinos, con datos de data912.

SeekingAlpha · 14 de sept de 2026
Cardinal Health, Inc. (CAH) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 8:30 AM EDTCompany ParticipantsDavid Frost - Vice...

Yahoo · 14 de sept de 2026
Amgen trades at a cheaper valuation but carries higher leverage, while Vertex boasts pristine finances and 32% net margins, a classic trade-off between value an…

Yahoo · 11 de sept de 2026
Cardinal Health's 29% rally reflects stronger specialty growth, MSO expansion and higher-margin assets, but cost pressures could test the uptrend.

Yahoo · 11 de sept de 2026
Amgen is profitable and paying a growing dividend, while Revolution Medicines is burning cash to fund what could be one of the most important cancer drug launch…

Yahoo · 11 de sept de 2026
One company is generating billions in revenue and raising its dividend. The other is burning cash in pursuit of a scientific breakthrough that could change how…
Noticias vía Finnhub